In agreement with other report (38), MAFLD patients more often had metabolic syndrome, had better synthetic liver function, less often had alpha fetoprotein concentration ≥ 400 ng/mL, tumor size ≥ 5 cm, multinodular, underwent major hepatectomy, and microvascular invasion compared to CHB counterparts at HCC diagnosis. This evidence concerns the gene AFP and metabolic syndrome.